FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira Diazepam Injection 10mg/2mL Recall

Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc

Hospira Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Jul 20, 2016
Recall ID
D-1359-2016
Check your lot numberHow we source this data

Summary

Hospira recalled Diazepam Injection 10mg/2mL starting Jun 23, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1359-2016 on Jul 20, 2016. Reason: Crystallization: Product contains particulate identified to be crystallized active ingredient. Status: Terminated.

Why it was recalled

Crystallization: Product contains particulate identified to be crystallized active ingredient.

Product description

Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake Forest, IL 60045, NDC 0409-1273-32

Lot numbers, UPCs & expiration codes

Lot #: 52610LL, Exp. 01 OCT 2016; Lot #: 57660LL, Exp. 01 MAR 2017

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1359-2016
Classification
Class II
Status
Terminated
Recall initiated
Jun 23, 2016
FDA report date
Jul 20, 2016
Quantity
373,850 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-1359-2016, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
74399
Address
275 N Field Dr
Code information
Lot #: 52610LL, Exp. 01 OCT 2016; Lot #: 57660LL, Exp. 01 MAR 2017
Postal code
60045-2579
Report date
Jul 20, 2016
Product type
Drugs
Recall number
D-1359-2016
Classification
Class II
Recalling firm
Hospira Inc.
Product quantity
373,850 tubes
Termination date
Aug 31, 2018
Reason for recall
Crystallization: Product contains particulate identified to be crystallized active ingredient.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake Forest, IL 60045, NDC 0409-1273-32
Distribution pattern
Nationwide
Recall initiation date
Jun 23, 2016
Initial firm notification
Letter
Center classification date
Jul 12, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1359-2016, published Jul 20, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls